Page last updated: 2024-10-23

bromhexine and Pericardial Effusion

bromhexine has been researched along with Pericardial Effusion in 1 studies

Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).

Pericardial Effusion: Fluid accumulation within the PERICARDIUM. Serous effusions are associated with pericardial diseases. Hemopericardium is associated with trauma. Lipid-containing effusion (chylopericardium) results from leakage of THORACIC DUCT. Severe cases can lead to CARDIAC TAMPONADE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hill, HC1

Other Studies

1 other study available for bromhexine and Pericardial Effusion

ArticleYear
Challenges of utilizing immunostains to facilitate the diagnosis and management of metastatic adenocarcinoma.
    Journal of the National Medical Association, 2008, Volume: 100, Issue:12

    Topics: Adenocarcinoma; Adult; Bone Neoplasms; Brain Neoplasms; Bromhexine; Fatal Outcome; Female; Humans; I

2008